Clinical Trials
4 trialsNCT05456269 2023-10-03
BISECT
Racura Oncology Ltd
Phase 1 Withdrawn
NCT05246384 2022-10-31
Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
Rhizen Pharmaceuticals SA
Phase 1/2 Withdrawn
NCT04264806 2022-05-20
A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)
Janssen Research & Development, LLC
Phase 2 Withdrawn
NCT04217720 2021-08-12
SNS-301 Monotherapy in High Risk MDS and CMML
Sensei Biotherapeutics, Inc.
Phase 2 Withdrawn